BeiGene Manufacturing and Clinical R&D Center, Phase I
BeiGene | Manufacturing and Clinical R&D Center, Phase I | Hopewell, NJ
BeiGene’s new 400,000-sq.-ft. state-of-the-art flagship U.S. Manufacturing and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, N.J will be focused on developing and commercializing innovative cancer medicines to improve treatment outcomes more affordably. This pharmaceutical campus will be comprised of five separate buildings—administration laboratory, drug substance, drug product, warehouse, and central utility plant all connected by a central utility spine.
DPR has been engaged with the project from preconstruction to construction. Since Hopewell is a bucolic town, the team has made it a priority to maintain its integrity by minimizing the impacts of construction. DPR has supported the client in navigating the state and local jurisdictional requirements for building a life science manufacturing facility, while identifying trade partners, and aligning scopes of work to keep the project on track and within budget.
Project
Milestones
A topping out celebrates the completion of the steel structures for three of the five ground-up buildings on the campus. The other two buildings will be built utilizing prefabricated modules that will be assembled onsite.
Steel erection began in November 2022 and was completed four months later, with a ceremony in March 2023.
At the time of the topping out, the project team had successfully:
- Removed 110,000 cubic yards of soil
- Poured 10,288 cubic yards of concrete, with 1,700 cubic yards pending
- Installed 363 tons of rebar
- Placed 3,783 total pieces of steel
- Completed 130,898 work hours
To support efficiency and worker safety, the DPR team used Synchro, an infrastructure construction management software, to track steel installation. They were able to pull data from Synchro to create visual dashboards to facilitate conversations regarding production, tracking, and sequencing. The steel model was imported into the virtual design and construction (VDC) coordination model to align with the MEP trades for penetrations and MEP placement.
Customer
Quote
At BeiGene, we are committed to not only delivering innovative and affordable medicines but also to upholding the highest standards of ethics and integrity, operational excellence, and environmental stewardship. This commitment applies to everything we do, including the development of BeiGene’s Hopewell project.
John V. Oyler, Co-Founder, Chairman and CEO of BeiGene
We think you'll like this, too.
